Araştırma Makalesi
BibTex RIS Kaynak Göster

Aydıntepe’de yaşayan bireylerde göz kuruluğu sıklığının ve risk faktörlerinin incelenmesi

Yıl 2022, Cilt: 11 Sayı: 1, 76 - 82, 28.02.2022
https://doi.org/10.53424/balikesirsbd.980452

Öz

Amaç: Bu çalışma, Bayburt İli Aydıntepe ilçesinde yaşayan bireylerde göz kuruluğu sıklığını ve risk faktörlerini belirlemek amacıyla yapılmıştır.
Yöntem: Tanımlayıcı ve kesitsel türde olan çalışmanın evrenini Aydıntepe Toplum Sağlığı Merkezine kayıtlı bulunan 2100 kişi, örneklemini ise anlama ve algılama problemi olmayan, 15 yaş ve üstü araştırmayı kabul eden 350 kişi oluşturmuştur. Veriler; Kasım 2019-Temmuz 2020 ayları “Tanıtıcı Bilgi Formu”, “Oküler Yüzey Hastalığı İndeksi Anketi” ve “Schirmer Testi” kullanılarak elde edilmiştir. Elde edilen veriler SPSS programı kullanılarak analizi değerlendirilmiştir.
Bulgular: Katılımcıların % 42.0’ının kronik hastalığının olduğu, % 66.3’ünün düzenli ilaç kullandığı ve % 62.6’sının göz hastalığının bulunduğu, OSDI anketine göre % 29.4’ünün hafif, % 22.0’ının orta, % 21.4’ünün ise ağır düzeyde kuru göz belirtilerinin olduğu, ağır düzeyde kuru göz belirtilerinin en çok 65 yaş ve üzerindeki katılımcılarda (% 38.1), burun ve boğaz kuruluğu yaşadığını ifade edenlerde (% 34.6) ve kronik bir hastalığa sahip olanlarda ( % 35.4) görüldüğü bulunmuştur. Cinsiyete göre kuru göz belirtileri arasında fark bulunmamıştır (p>0.05).
Sonuç: Bayburt İli Aydıntepe İlçesinde yaşayan ve çalışmaya katılan bireylerin çoğunda farklı düzeylerde göz kuruluğu olduğu, ileri yaştaki bireylerde, herhangi kronik hastalığı olanlarda göz kuruluğu görülme oranlarının daha fazla olduğu sonucuna ulaşılmıştır.

Kaynakça

  • Alharbi, O.O., Beyari, G.M., Saber, W.A., Alotaibi, A.F., Bukannan, A.Y., & Mohamed, Y.N. (2020). Etiology, prevalence, risk factors, and treatment of dry eye disease. International Journal of Medicine in Developing Countries, 4(1), 137–142.
  • Alshamrani, A.A., Almousa, A.S., Almulhim, A.A., Alafaleq, A.A., Alosaimi, M.B., Alqahtani, A.M., Almulhem. A.M., Alshamrani, M.A., Alhallafi, A.H., Alqahtani I.Z., & Alshehri A.A. (2017). Prevalence and risk factors of dry eye symptoms in a Saudi Arabian population. Middle East Afr J Ophthalmol, 24(2), 67-73.
  • Bawazeer, A.M., & Hodge W.G. (2003). One-minute Schirmer test with anesthesia. Cornea, 22(4), 285–287.
  • Birinci, S. (2013). Bayburt İlinin Coğrafyası (Doktora Tezi). Atatürk Üniversitesi Coğrafya Anabilim Dalı, Erzurum.
  • Çapık, C. (2014). İstatistiksel güç analizi ve hemşirelik araştırmalarında kullanımı: Temel bilgiler. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi, 17(4), 268-274.
  • Dilly, PN. (1994). Structure and function of the tear film. Içinde: Advances in Experimental Medicine and Biology. C 350. Springer, Boston, MA, 239–247.
  • Farrand, K.F., Fridman, M., Stillman, I.Ö., & Schaumberg, D.A. (2017). Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. American Journal of Ophthalmology, 182, 90-98.
  • Hashemi, H., Khabazkhoob, M., Kheirkhah, A., Emamian, M.H., Mehravaran, S., Shariati, M., & Fotouhi, A. (2013). Prevalence of dry eye syndrome in an adult population. Clin Exp Ophthalmol, 42(3), 242–8. Herdman, T. H. (ed.) (2012). NANDA International. Nursing diagnoses: Definitions and classification, 2012–2014. Ames, IA: Wiley-Blackwell.
  • Kyei, S., Dzasimatu, S.K., Asiedu, K., & Ayerakwah, P.A. (2018). Association between dry eye symptoms and signs. Journal of Current Ophthalmology, 30(4), 321-325.
  • Lemp, M.A. (2008). Advances in Understanding and Managing Dry Eye Disease. Am J Ophthalmol, 146-3.
  • Li, X., Hu, L., Hu, J., & Wang, W. (2007). Investigation of Dry Eye Disease and Analysis of the Pathogenic Factors in Patients after Cataract Surgery. Kornea, 26, 16-20. Makrynioti, D., Zagoriti, Z., Koutsojannis, C., Morgan, P.B, & Lagoumintzis, G. (2020). Ocular conditions and dry eye due to traditional and new forms of smoking: A review. Contact Lens Anterior Eye, 43(3), 277-284.
  • Moss, S.E., Klein, R., & Klein, B.E. (2000). Prevalance of and risk factors for dry eye syndrome. Arch Ophthalmol, 118(9), 1264–1268.
  • Nichols, K.K., Nichols, J.J., & Mitchell, G.L. (2004). The lack of association between signs and symptoms in patients with dry eye disease. Cornea, 23(8):762-70
  • Özcura, F., Aydın, S., & Helvaci, M.R. (2007). Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm, 15(5), 389–393.
  • Perry, H.D. (2008). Dry eye disease: Pathophysiology, classification, and diagnosis. Am J Manag Care, 14-3.
  • Saldanha, L.J., Petris, R., Makara, M., Channa, P., & Akpek E.K. (2021). Impact of the COVID-19 pandemic on eye strain and dry eye symptoms. The Ocular Surface, 38-46.
  • Schaumberg, D.A., Dana, R., Buring, J.E., & Sullivan, D.A. (2009). Prevalence of dry eye disease among US men: Estimates from the physicians’ health studies. Arch Ophthalmol, 127-6, 763–768.
  • Schiffman, R.M., Christianson, M.D., Jacobsen, G., Hirsch, J.D., & Reis, B.L. (2000). Reliability and validity of the ocular surface disease index. Arch Ophthalmol, 118(5):615-21.
  • Senchyna, M., & Wax, M.B. (2008). Quantitative assessment of tear production: A review of methods and utility in dry eye drug discovery. Journal of Ocular Biology, Diseases, and Informatics,1(1), 1–6.
  • Shilpy, N., & Patel, D.B. (2019). Prevalence of dry eye disease in Western India. International Journal of Contemporary Medical Research, 6(7), 10-12.
  • Titiyal, J.S., Falera, R.C., Kaur, M., Sharma, V., & Sharma, N. (2018). Prevalence and risk factors of dry eye disease in North India: Ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol, 66(2), 207–211.
  • Toda, I., Fujishima, H., & Tsubota, K. (1993). Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol, 71(3), 347–352.
  • Uchino M, Yokoi N, Uchino Y, et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: The Osaka study. Am J Ophthalmol. 2013; 156(4):759-66. doi:10.1016/j.ajo.2013.05.040.
  • Uchino, M., Nishiwaki, Y., Michikawa, T., Shirakawa, K., Kuwahara, E., Yamada, M., Dogru, M., Schaumberg, D.A., Kawakita, T., Takebayashi, T., & Tsubota, K. (2011). Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology, 118(12), 2361-7.
  • Vehof, J., Snieder, H., Jansonius, N., & Hammond, C.J. (2021). Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf, 19: 83-93. doi: 10.1016/j.jtos.2020.04.005
  • Wilkinson, J., Barcus, L. (2018). Person hemşirelik tanıları kitabı. Ankara: Pelikan Yayınevi.
  • Xu, L., Zhang, W., Zhu, X.Y., Suo, T, Fun, X.Q., & Fu, Y. (2016). Smoking and the risk of dry eye: A meta-analysis. Int J Ophthalmol, 9(10), 1480–1486.

Investigation of Dry Eye Frequency and Rısk Factors in Indıvıduals Living in Aydıntepe

Yıl 2022, Cilt: 11 Sayı: 1, 76 - 82, 28.02.2022
https://doi.org/10.53424/balikesirsbd.980452

Öz

Objective: This study was carried out to determine the frequency and risk factors of dry eye in individuals living in Aydıntepe district of Bayburt.
Method: The population of the study, which is descriptive and cross-sectional, consists of 2100 people registered in Aydıntepe Community Health Center, and the sample consists of 350 people aged 15 and over who accept the study, who do not have understanding and perception problems. Data; The months of November 2019-July 2020 were obtained using the "Introductory Information Form", "Ocular Surface Disease Index Questionnaire" and "Schirmer Test". The obtained data were analyzed using the SPSS program.
Results: 42.0% of the participants had chronic disease, 66.3% had regular medication and 62.6% had eye disease, according to the OSDI survey, 29.4% had mild, 22.0% had moderate, and 21.4% had severe dryness. It was found that severe dry eye symptoms were most common in participants aged 65 years and older (38.1%), those who stated that they experienced dry nose and throat (34.6%), and those with a chronic disease (35.4%). There was no difference in dry eye symptoms according to gender (p> 0.05).
Conclusion: It has been concluded that most of the individuals living in Aydıntepe District of Bayburt and participating in the study have different levels of dry eye, and the incidence of dry eye is higher in elderly individuals and those with any chronic disease.

Kaynakça

  • Alharbi, O.O., Beyari, G.M., Saber, W.A., Alotaibi, A.F., Bukannan, A.Y., & Mohamed, Y.N. (2020). Etiology, prevalence, risk factors, and treatment of dry eye disease. International Journal of Medicine in Developing Countries, 4(1), 137–142.
  • Alshamrani, A.A., Almousa, A.S., Almulhim, A.A., Alafaleq, A.A., Alosaimi, M.B., Alqahtani, A.M., Almulhem. A.M., Alshamrani, M.A., Alhallafi, A.H., Alqahtani I.Z., & Alshehri A.A. (2017). Prevalence and risk factors of dry eye symptoms in a Saudi Arabian population. Middle East Afr J Ophthalmol, 24(2), 67-73.
  • Bawazeer, A.M., & Hodge W.G. (2003). One-minute Schirmer test with anesthesia. Cornea, 22(4), 285–287.
  • Birinci, S. (2013). Bayburt İlinin Coğrafyası (Doktora Tezi). Atatürk Üniversitesi Coğrafya Anabilim Dalı, Erzurum.
  • Çapık, C. (2014). İstatistiksel güç analizi ve hemşirelik araştırmalarında kullanımı: Temel bilgiler. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi, 17(4), 268-274.
  • Dilly, PN. (1994). Structure and function of the tear film. Içinde: Advances in Experimental Medicine and Biology. C 350. Springer, Boston, MA, 239–247.
  • Farrand, K.F., Fridman, M., Stillman, I.Ö., & Schaumberg, D.A. (2017). Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. American Journal of Ophthalmology, 182, 90-98.
  • Hashemi, H., Khabazkhoob, M., Kheirkhah, A., Emamian, M.H., Mehravaran, S., Shariati, M., & Fotouhi, A. (2013). Prevalence of dry eye syndrome in an adult population. Clin Exp Ophthalmol, 42(3), 242–8. Herdman, T. H. (ed.) (2012). NANDA International. Nursing diagnoses: Definitions and classification, 2012–2014. Ames, IA: Wiley-Blackwell.
  • Kyei, S., Dzasimatu, S.K., Asiedu, K., & Ayerakwah, P.A. (2018). Association between dry eye symptoms and signs. Journal of Current Ophthalmology, 30(4), 321-325.
  • Lemp, M.A. (2008). Advances in Understanding and Managing Dry Eye Disease. Am J Ophthalmol, 146-3.
  • Li, X., Hu, L., Hu, J., & Wang, W. (2007). Investigation of Dry Eye Disease and Analysis of the Pathogenic Factors in Patients after Cataract Surgery. Kornea, 26, 16-20. Makrynioti, D., Zagoriti, Z., Koutsojannis, C., Morgan, P.B, & Lagoumintzis, G. (2020). Ocular conditions and dry eye due to traditional and new forms of smoking: A review. Contact Lens Anterior Eye, 43(3), 277-284.
  • Moss, S.E., Klein, R., & Klein, B.E. (2000). Prevalance of and risk factors for dry eye syndrome. Arch Ophthalmol, 118(9), 1264–1268.
  • Nichols, K.K., Nichols, J.J., & Mitchell, G.L. (2004). The lack of association between signs and symptoms in patients with dry eye disease. Cornea, 23(8):762-70
  • Özcura, F., Aydın, S., & Helvaci, M.R. (2007). Ocular surface disease index for the diagnosis of dry eye syndrome. Ocul Immunol Inflamm, 15(5), 389–393.
  • Perry, H.D. (2008). Dry eye disease: Pathophysiology, classification, and diagnosis. Am J Manag Care, 14-3.
  • Saldanha, L.J., Petris, R., Makara, M., Channa, P., & Akpek E.K. (2021). Impact of the COVID-19 pandemic on eye strain and dry eye symptoms. The Ocular Surface, 38-46.
  • Schaumberg, D.A., Dana, R., Buring, J.E., & Sullivan, D.A. (2009). Prevalence of dry eye disease among US men: Estimates from the physicians’ health studies. Arch Ophthalmol, 127-6, 763–768.
  • Schiffman, R.M., Christianson, M.D., Jacobsen, G., Hirsch, J.D., & Reis, B.L. (2000). Reliability and validity of the ocular surface disease index. Arch Ophthalmol, 118(5):615-21.
  • Senchyna, M., & Wax, M.B. (2008). Quantitative assessment of tear production: A review of methods and utility in dry eye drug discovery. Journal of Ocular Biology, Diseases, and Informatics,1(1), 1–6.
  • Shilpy, N., & Patel, D.B. (2019). Prevalence of dry eye disease in Western India. International Journal of Contemporary Medical Research, 6(7), 10-12.
  • Titiyal, J.S., Falera, R.C., Kaur, M., Sharma, V., & Sharma, N. (2018). Prevalence and risk factors of dry eye disease in North India: Ocular surface disease index-based cross-sectional hospital study. Indian J Ophthalmol, 66(2), 207–211.
  • Toda, I., Fujishima, H., & Tsubota, K. (1993). Ocular fatigue is the major symptom of dry eye. Acta Ophthalmol, 71(3), 347–352.
  • Uchino M, Yokoi N, Uchino Y, et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: The Osaka study. Am J Ophthalmol. 2013; 156(4):759-66. doi:10.1016/j.ajo.2013.05.040.
  • Uchino, M., Nishiwaki, Y., Michikawa, T., Shirakawa, K., Kuwahara, E., Yamada, M., Dogru, M., Schaumberg, D.A., Kawakita, T., Takebayashi, T., & Tsubota, K. (2011). Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology, 118(12), 2361-7.
  • Vehof, J., Snieder, H., Jansonius, N., & Hammond, C.J. (2021). Prevalence and risk factors of dry eye in 79,866 participants of the population-based Lifelines cohort study in the Netherlands. Ocul Surf, 19: 83-93. doi: 10.1016/j.jtos.2020.04.005
  • Wilkinson, J., Barcus, L. (2018). Person hemşirelik tanıları kitabı. Ankara: Pelikan Yayınevi.
  • Xu, L., Zhang, W., Zhu, X.Y., Suo, T, Fun, X.Q., & Fu, Y. (2016). Smoking and the risk of dry eye: A meta-analysis. Int J Ophthalmol, 9(10), 1480–1486.
Toplam 27 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Konular Sağlık Kurumları Yönetimi
Bölüm Makaleler
Yazarlar

Arzu Çimen 0000-0003-1983-9140

Reva Balcı Akpınar 0000-0001-8796-6497

Yayımlanma Tarihi 28 Şubat 2022
Gönderilme Tarihi 9 Ağustos 2021
Yayımlandığı Sayı Yıl 2022 Cilt: 11 Sayı: 1

Kaynak Göster

APA Çimen, A., & Balcı Akpınar, R. (2022). Aydıntepe’de yaşayan bireylerde göz kuruluğu sıklığının ve risk faktörlerinin incelenmesi. Balıkesir Sağlık Bilimleri Dergisi, 11(1), 76-82. https://doi.org/10.53424/balikesirsbd.980452

Uluslararası Hakemli Dergi

Dergimiz Açık Erişim Politikasını benimsemiş olup dergimize gönderilen yayınlar için gerek değerlendirme gerekse yayınlama dahil yazarlardan hiçbir ücret talep edilmemektedir. 

Creative Commons License

Bu eser Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.